Nova Patents
AT293123T

Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues

Abstract

The invention relates to novel and tricyclic ring whose nucleotide and analogue and an comprising the oligonucleotides. Wherein the nucleotide, comprising LNAs (block system prepared analog), so and DNA oligonucleotide of valuable the improved of said and specific oligonucleotides to total RNA. Oligonucleotide and method for LNAs of the novel LNA modified diagnostics and application of claims 1-15 for use of widespread. The mention of the antisense to be, PCR to be chain, the second and is the nucleotide polymerase the substrate and is nucleotide-based of ABR+OBR process in.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

55 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
105497DenmarkA
149297DenmarkA
6198DenmarkA
28698DenmarkA
58598DenmarkA
8830998United States of AmericaP
75098DenmarkA
PA199800982DenmarkA
9800393DenmarkW

Members55

Family members, oldest first
DocumentOfficeKind
CA2303299A1CanadaA1
WO9914226A2World Intellectual Property Organization (WIPO)A2
AU9063398AAustraliaA
WO9914226A3World Intellectual Property Organization (WIPO)A3
EP1015469A2European Patent Office (EPO)A2
CN1279687AChinaA
KR20010030586ARepublic of KoreaA
IL135000D0IsraelD0
HK1033946A1Hong Kong, ChinaA1
NZ503765ANew ZealandA
US2002068708A1United States of AmericaA1
JP2002521310AJapanA
US2003134808A1United States of AmericaA1
US2003144231A1United States of AmericaA1
US6670461B1United States of AmericaB1
KR100414936B1Republic of KoreaB1
US6794499B2United States of AmericaB2
RU2243231C2Russian FederationC2
EP1015469B1European Patent Office (EPO)B1
AT293123TThis recordAustriaT
ATE293123T1AustriaT1
DE69829760D1GermanyD1
EP1557424A1European Patent Office (EPO)A1
ES2242291T3SpainT3
US2005287566A1United States of AmericaA1
DE04020014T1GermanyT1
DE69829760T2GermanyT2
US7034133B2United States of AmericaB2
CN1273476CChinaC
JP2007211025AJapanA
IL185568D0IsraelD0
IL185569D0IsraelD0
IL185570D0IsraelD0
JP4236812B2JapanB2
US7572582B2United States of AmericaB2
US2010267018A1United States of AmericaA1
US2010279895A1United States of AmericaA1
EP2253639A1European Patent Office (EPO)A1
EP2341057A2European Patent Office (EPO)A2
EP2341058A2European Patent Office (EPO)A2
US2011245327A1United States of AmericaA1
US8034909B2United States of AmericaB2
EP2341057A3European Patent Office (EPO)A3
EP2341058A3European Patent Office (EPO)A3
IL135000AIsraelA
IL185568AIsraelA
US8080644B2United States of AmericaB2
IL185569AIsraelA
IL185570AIsraelA
US8153365B2United States of AmericaB2
JP5677716B2JapanB2
EP1015469B2European Patent Office (EPO)B2
CA2303299CCanadaC
ES2242291T5SpainT5
DE69829760T3GermanyT3